CAMP4 Therapeutics
Kevin Stansky began their career at Hydra Biosciences as a Research Intern before moving on to roles at Boston Children's Hospital, Harvard Medical School, and Trinity Partners as a Consultant. Kevin then transitioned to the pharmaceutical industry, working at Sanofi Genzyme and Biogen in various Business Development and Managerial positions. Currently, Kevin is serving as the Senior Director of Portfolio Strategy and Program Leadership at CAMP4 Therapeutics. Throughout their career, Kevin has demonstrated expertise in new product planning, global marketing, and market sizing strategies. Kevin holds a Master of Business Administration from Harvard Business School and graduated Magna cum Laude with a degree in Biology from Bowdoin College.
CAMP4 Therapeutics
1 followers
CAMP4 Therapeutics is pioneering a new approach to upregulate genes by targeting regulatory RNA using programmable oligonucleotide therapeutics.